Literature DB >> 2537848

A phosphoprotein of Mr 47,000, defective in autosomal chronic granulomatous disease, copurifies with one of two soluble components required for NADPH:O2 oxidoreductase activity in human neutrophils.

B G Bolscher1, R van Zwieten, I M Kramer, R S Weening, A J Verhoeven, D Roos.   

Abstract

The NADPH:O2 oxidoreductase (NADPH oxidase) of human neutrophils is converted from a dormant to an active state upon stimulation of the cells. We have studied the soluble fraction that is required for NADPH oxidase activation in a cell-free system. Human neutrophils were separated in a membrane-containing and a soluble fraction. The soluble fraction was separated on carboxymethyl (CM) Sepharose in 10 mM 4-morpholino-ethanesulfonic acid buffer of pH 6.8. Reconstitution of the NADPH oxidase activity, measured as O2 consumption, was only found when the membrane fraction was combined with the flowthrough of the CM Sepharose column as well as with a fraction that eluted at 125 mM NaCl. This result indicates that at least two soluble components are necessary for reconstitution of the NADPH oxidase activity: one that does not bind to CM Sepharose and one that does bind. These components were designated soluble oxidase component (SOC) I and SOC II, respectively. Boiling destroyed the activity in both fractions. In the soluble fraction of human lymphocytes and thrombocytes neither SOC I nor SOC II activity was found. SOC II copurified with a 47-kD phosphoprotein, previously found defective in patients with the autosomal form of chronic granulomatous disease (CGD). Inactive soluble fractions of cells from autosomal CGD patients were reconstituted with a SOC II fraction from control cells. The result of this experiment indicates that autosomal CGD patients are normal in SOC I but defective in SOC II.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537848      PMCID: PMC303744          DOI: 10.1172/JCI113954

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes.

Authors:  A J SBARRA; M L KARNOVSKY
Journal:  J Biol Chem       Date:  1959-06       Impact factor: 5.157

2.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

3.  Analysis of human class I antigens by two-dimensional gel electrophoresis. I. Polymorphism, evidence for additional (non-HLA-A, B, C) gene products, and identification of variant HLA-A, B antigens.

Authors:  R G Vasilov; A Hahn; H Mölders; J J van Rood; M Breuning; H L Ploegh
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

4.  Isolation of large numbers of highly purified lymphocytes and monocytes with a modified centrifugal elutriation technique.

Authors:  C G Figdor; W S Bont; J E De Vries; W L Van Es
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

5.  Calcium-activated, phospholipid-dependent protein kinase from rat brain. Subcellular distribution, purification, and properties.

Authors:  U Kikkawa; Y Takai; R Minakuchi; S Inohara; Y Nishizuka
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

6.  Activation of protein kinase C in neutrophil cytoplasts. Localization of protein substrates and possible relationship with stimulus-response coupling.

Authors:  R Gennaro; C Florio; D Romeo
Journal:  FEBS Lett       Date:  1985-01-28       Impact factor: 4.124

7.  Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function.

Authors:  B Holmes; A R Page; R A Good
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

8.  Subcellular localization of the human neutrophil NADPH oxidase. b-Cytochrome and associated flavoprotein.

Authors:  N Borregaard; A I Tauber
Journal:  J Biol Chem       Date:  1984-01-10       Impact factor: 5.157

9.  Complementation in monocyte hybrids revealing genetic heterogeneity in chronic granulomatous disease.

Authors:  M N Hamers; M de Boer; L J Meerhof; R S Weening; D Roos
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

10.  Functional activity of enucleated human polymorphonuclear leukocytes.

Authors:  D Roos; A A Voetman; L J Meerhof
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

View more
  16 in total

Review 1.  Chronic granulomatous disease.

Authors:  D Goldblatt; A J Thrasher
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

2.  Cooperation of p40(phox) with p47(phox) for Nox2-based NADPH oxidase activation during Fcγ receptor (FcγR)-mediated phagocytosis: mechanism for acquisition of p40(phox) phosphatidylinositol 3-phosphate (PI(3)P) binding.

Authors:  Takehiko Ueyama; Junya Nakakita; Takashi Nakamura; Takeshi Kobayashi; Toshihiro Kobayashi; Jeonghyun Son; Megumi Sakuma; Hirofumi Sakaguchi; Thomas L Leto; Naoaki Saito
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

Review 3.  Protein phosphorylation associated with the stimulation of neutrophils. Modulation of superoxide production by protein kinase C and calcium.

Authors:  P G Heyworth; J A Badwey
Journal:  J Bioenerg Biomembr       Date:  1990-02       Impact factor: 2.945

4.  Chronic bullous disease of childhood and a paecilomyces lung infection in chronic granulomatous disease.

Authors:  J H Sillevis Smitt; J H Leusen; H G Stas; A H Teeuw; R S Weening
Journal:  Arch Dis Child       Date:  1997-08       Impact factor: 3.791

5.  Genes for two autosomal recessive forms of chronic granulomatous disease assigned to 1q25 (NCF2) and 7q11.23 (NCF1).

Authors:  U Francke; C L Hsieh; B E Foellmer; K J Lomax; H L Malech; T L Leto
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

6.  Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease.

Authors:  M C Dinauer; E A Pierce; G A Bruns; J T Curnutte; S H Orkin
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

7.  Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor.

Authors:  Kazufumi Hirano; Woei Shin Chen; Adeline L W Chueng; Angela A Dunne; Tamara Seredenina; Aleksandra Filippova; Sumitra Ramachandran; Angela Bridges; Laiq Chaudry; Gary Pettman; Craig Allan; Sarah Duncan; Kiew Ching Lee; Jean Lim; May Thu Ma; Agnes B Ong; Nicole Y Ye; Shabina Nasir; Sri Mulyanidewi; Chiu Cheong Aw; Pamela P Oon; Shihua Liao; Dizheng Li; Douglas G Johns; Neil D Miller; Ceri H Davies; Edward R Browne; Yasuji Matsuoka; Deborah W Chen; Vincent Jaquet; A Richard Rutter
Journal:  Antioxid Redox Signal       Date:  2015-08-10       Impact factor: 8.401

8.  Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase.

Authors:  B D Volpp; W M Nauseef; J E Donelson; D R Moser; R A Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

Review 9.  Mechanisms for the activation/electron transfer of neutrophil NADPH-oxidase complex and molecular pathology of chronic granulomatous disease.

Authors:  S Umeki
Journal:  Ann Hematol       Date:  1994-06       Impact factor: 3.673

Review 10.  The involvement of oxygen radicals in microbicidal mechanisms of leukocytes and macrophages.

Authors:  D Roos
Journal:  Klin Wochenschr       Date:  1991-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.